Textbook of Medical Physiology

the Collecting severe acute kidney injury, in which the kidneys Tubules may abruptly stop working entirely or almost en- Spironolactone and eplerenone are mineralocorticoid tirely, necessitating renal replacement therapy such receptor antagonists that compete with aldosterone for as dialysis, as discussed later in this chapter. In some receptor- binding sites in the collecting tubule and col- cases, patients with AKI may eventually recover lecting duct epithelial cells and, therefore, can decrease nearly normal kidney function. the reabsorption of sodium and secretion of potassium 2. Chronic kidney disease (CKD), in which there is in these tubular segments (see Figure 28- 12). As a con- progressive loss of function of more and more sequence, sodium remains in the tubules and acts as an nephrons that gradually decreases overall kidney osmotic diuretic, causing increased excretion of water, as function. well as sodium. Because these drugs also block the effect Within these two general categories, there are many of aldosterone to promote potassium secretion in the specific kidney diseases that can affect the kidney blood tubules, they decrease the excretion of potassium. vessels, glomeruli, tubules, renal interstitium, and parts of Mineralocorticoid receptor antagonists also cause the urinary tract outside the kidney, including the ureters
